Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy

Addiction. 2022 Jun;117(6):1818-1819. doi: 10.1111/add.15830. Epub 2022 Feb 14.

Author

Rose A Schmidt^{1

2}

Affiliations

¹ Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
² Centre for Addiction and Mental Health (CAMH), Institute for Mental Health Policy Research and Campbell Family Mental Health Research Institute, Toronto, Canada.

PMID: 35129228
DOI: 10.1111/add.15830

No abstract available

Keywords: Medication for opioid use disorder; comment; epidemiology; postpartum; pregnancy; substance use disorder.

Publication types

Letter
Comment

MeSH terms

Buprenorphine* / therapeutic use
Female
Humans
Opioid-Related Disorders* / drug therapy
Pregnancy

Substances

Buprenorphine